Martha Neagu Aristide

Company: Abbvie

Job title: Senior Medical Director

Seminars:

Panel Discussion: Overviewing & Investigating Success Stories of Crossing the BBB: What are the Mechanisms of Penetration & How Does this Effect Drug Efficacy? 11:30 am

Discussing new technologies emerging that manipulate the BBB to deliver therapeutic agents directly to the tumor site Recounting case studies of success stories in crossing the BBB – how can this be applied? Examining the standard differences in delivery between the US and EuropeRead more

day: Conference Day 2

Enhancing Antibody Drug Conjugates Efficacy in Glioblastoma through Overcoming Blood-Brain Barrier Challenges 8:30 am

Due to the restrictive nature of the blood-brain barrier, there are many difficulties in drug delivery to the GBM. While ADCs offer targeted therapy by linking monoclonal antibodies with cytotoxic agents, their effectiveness in GBM is hindered by the BBB’s physical and biochemical barriers. This workshop will provide an in-depth examination of the strategies to…Read more

day: Workshop B (New)